149 related articles for article (PubMed ID: 26845207)
1. [Management of antirheumatic drugs in kidney failure].
Manganelli R; Manganelli S; Iannaccone S; De Simone W
G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845207
[TBL] [Abstract][Full Text] [Related]
2. [Institute of Rheumatology and progress of antirheumatic therapy].
Sigidin IaA
Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
[TBL] [Abstract][Full Text] [Related]
3. Use of MTX in the elderly and in patients with compromised renal function.
Morgacheva O; Furst DE
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S85-94. PubMed ID: 21044439
[TBL] [Abstract][Full Text] [Related]
4. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
Schiff MH; Whelton A
Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of rheumatic disease with renal insufficiency].
Weiner SM
Orthopade; 2019 Nov; 48(11):927-935. PubMed ID: 31531703
[TBL] [Abstract][Full Text] [Related]
6. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
Conaghan PG; Brooks P
Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
[TBL] [Abstract][Full Text] [Related]
7. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?
Ostensen M; Ramsey-Goldman R
Drug Saf; 1998 Nov; 19(5):389-410. PubMed ID: 9825952
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics in rheumatology and the kidney.
Harty T; O'Shaughnessy M; Harney S
Rheumatology (Oxford); 2023 Mar; 62(3):1009-1020. PubMed ID: 35951751
[TBL] [Abstract][Full Text] [Related]
9. Proposal for a new nomenclature of disease-modifying antirheumatic drugs.
Smolen JS; van der Heijde D; Machold KP; Aletaha D; Landewé R
Ann Rheum Dis; 2014 Jan; 73(1):3-5. PubMed ID: 24072562
[TBL] [Abstract][Full Text] [Related]
10. Dosing of antirheumatic drugs in renal disease and dialysis.
Swarup A; Sachdeva N; Schumacher HR
J Clin Rheumatol; 2004 Aug; 10(4):190-204. PubMed ID: 17043508
[TBL] [Abstract][Full Text] [Related]
11. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
[TBL] [Abstract][Full Text] [Related]
12. Antirheumatic drugs in pregnancy and lactation.
Temprano KK; Bandlamudi R; Moore TL
Semin Arthritis Rheum; 2005 Oct; 35(2):112-21. PubMed ID: 16194696
[TBL] [Abstract][Full Text] [Related]
13. [Dosage and toxicity of antirheumatic drugs in renal insufficiency].
Weiner SM; Bergner R
Z Rheumatol; 2015 May; 74(4):300-9. PubMed ID: 25962451
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological management of inflammatory rheumatic conditions].
Bannwarth B
Therapie; 2011; 66(5):377-81. PubMed ID: 22031680
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapies in rheumatologic disorders.
Miller AV; Ranatunga SK
Med Clin North Am; 2012 May; 96(3):475-96, ix-x. PubMed ID: 22703852
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
Wiland P; Szechiński J
Arch Immunol Ther Exp (Warsz); 1994; 42(4):331-6. PubMed ID: 7487376
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in pediatric rheumatology.
Becker ML
Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics: implications for therapy in rheumatic diseases.
Davila L; Ranganathan P
Nat Rev Rheumatol; 2011 Aug; 7(9):537-50. PubMed ID: 21826093
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
20. BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.
Ledingham J; Gullick N; Irving K; Gorodkin R; Aris M; Burke J; Gordon P; Christidis D; Galloway S; Hayes E; Jeffries A; Mercer S; Mooney J; van Leuven S; Galloway J;
Rheumatology (Oxford); 2017 Jun; 56(6):865-868. PubMed ID: 28339817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
